tiprankstipranks
Trending News
More News >
Premier Health of America Inc (TSE:PHA)
:PHA
Canadian Market

Premier Health of America Inc (PHA) AI Stock Analysis

Compare
10 Followers

Top Page

TS

Premier Health of America Inc

(PHA)

Rating:46Neutral
Price Target:
C$0.00
▼(-100.00%Downside)
The overall stock score reflects significant financial and operational challenges, with high leverage and negative valuation metrics. Technical analysis shows bearish trends, compounded by recent corporate events indicating strategic reorientation amidst financial struggles.

Premier Health of America Inc (PHA) vs. iShares MSCI Canada ETF (EWC)

Premier Health of America Inc Business Overview & Revenue Model

Company DescriptionPremier Health of America Inc., a specialized healthcare services company, provides staffing and outsourced service solutions for healthcare needs in Canada. It also offers health consulting, nursing, and health-care services in remote communities, as well as medical transport services; and Code Bleu, an agency to employ nurses, caregivers, dental staff, and other health-related personnel. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company was founded in 2003 and is headquartered in Blainville, Canada.
How the Company Makes MoneyPremier Health of America Inc generates revenue primarily through its staffing and outsourcing services within the healthcare sector. The company earns money by supplying qualified healthcare professionals, such as nurses and support staff, to healthcare facilities that require additional workforce support. These services are typically billed on a contractual or per-hour basis, depending on the needs of the client. PHA also engages in partnerships with various healthcare institutions to provide tailored staffing solutions, which contribute significantly to its earnings. Additionally, the company's focus on efficient service delivery and maintaining strong client relationships aids in sustaining long-term revenue streams.

Premier Health of America Inc Financial Statement Overview

Summary
The company faces financial hurdles with declining profitability and increasing leverage. The income statement reflects operational inefficiencies and revenue volatility, while the balance sheet indicates high leverage and reduced equity. Cash flow improvements provide some hope, but sustained efforts are needed to stabilize financial performance.
Income Statement
55
Neutral
Premier Health of America Inc shows declining revenue with a negative net income in the TTM period, indicating financial challenges. Gross profit margin has decreased, and negative EBIT and EBITDA margins signal struggles in operational efficiency. The revenue growth rate is fluctuating, with a significant increase from 2021 to 2023 but a recent decline in 2024.
Balance Sheet
40
Negative
The company has a high debt-to-equity ratio due to substantial debt levels compared to equity, highlighting financial risk. Return on Equity is negative due to net losses, and the equity ratio has declined significantly, indicating higher leverage and reduced financial stability.
Cash Flow
65
Positive
Positive operating cash flow in the TTM period suggests some operational strength despite net losses. Free cash flow has shown improvement recently, albeit from negative levels in previous years, indicating better capital expenditure management. However, the free cash flow to net income ratio is negatively impacted by net losses.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
153.35M158.19M90.39M80.51M66.63M20.74M
Gross Profit
21.54M27.89M23.34M20.08M16.25M5.71M
EBIT
-2.84M-787.00K3.33M2.34M3.44M1.97M
EBITDA
-2.01M384.00K5.87M5.61M5.90M804.93K
Net Income Common Stockholders
-14.52M-12.49M-1.70M-111.51K1.50M27.92K
Balance SheetCash, Cash Equivalents and Short-Term Investments
37.00K1.50M1.15M5.12M2.68M1.23M
Total Assets
70.58M73.72M56.71M57.09M39.13M8.72M
Total Debt
51.83M49.85M27.27M22.84M12.30M2.73M
Net Debt
51.79M48.36M26.12M17.71M9.62M1.50M
Total Liabilities
68.74M69.64M40.27M38.62M21.81M4.85M
Stockholders Equity
1.85M4.08M16.44M18.47M17.32M3.87M
Cash FlowFree Cash Flow
3.66M3.02M-3.20M3.38M24.13K479.20K
Operating Cash Flow
6.65M5.93M-1.27M4.04M1.97M804.89K
Investing Cash Flow
-3.98M-26.43M-3.33M-12.67M-16.08M894.94K
Financing Cash Flow
-3.42M20.85M625.00K11.07M15.56M-424.55K

Premier Health of America Inc Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.07
Price Trends
50DMA
0.07
Positive
100DMA
0.10
Negative
200DMA
0.13
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
48.57
Neutral
STOCH
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PHA, the sentiment is Neutral. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.07, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 48.57 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:PHA.

Premier Health of America Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSEXE
73
Outperform
C$1.21B15.8071.61%3.33%9.38%117.85%
TSSIA
72
Outperform
C$1.71B43.836.93%5.04%8.76%14.05%
TSNLH
72
Outperform
C$23.84M20.684.53%4.09%
65
Neutral
C$173.09M-4.48%-0.69%8.08%
53
Neutral
$5.23B3.23-44.27%2.82%16.82%0.11%
TSPHA
46
Neutral
C$3.77M-239.50%3.03%-410.90%
$218.78M2.4133.87%2.26%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:PHA
Premier Health of America Inc
0.07
-0.31
-81.58%
TSE:CRRX
CareRx
2.89
0.54
22.98%
TSE:EXE
Extendicare
14.41
7.19
99.58%
TSE:NLH
Nova Leap Health
0.27
-0.04
-12.90%
TSE:SIA
Sienna Senior Living
18.58
4.62
33.09%
MFCSF
Medical Facilities
11.17
2.00
21.81%

Premier Health of America Inc Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Premier Health of America Announces CFO Transition
Neutral
May 26, 2025

Premier Health of America Inc. announced a transition in its CFO position, appointing Frédéric St-Cyr as the Interim Chief Financial Officer. This change follows the previous CFO, Guy Daoust, taking on the role of interim CEO. The appointment of St-Cyr, who has a strong background in finance and accounting, is expected to support the company during this transition period. This strategic move is likely to impact the company’s operations by ensuring continuity in financial leadership, which is crucial for maintaining its market position in the healthtech industry.

Business Operations and StrategyFinancial Disclosures
Premier Health of America Reports Q2 2025 Financial Results Amidst Market Challenges
Negative
May 21, 2025

Premier Health of America Inc. reported its second quarter 2025 financial results, highlighting a significant decline in revenues and adjusted EBITDA compared to the previous year, primarily due to decreased volumes in Quebec and British Columbia. The company is undergoing a reorganization, particularly in Quebec, to adapt to market conditions and regulatory impacts such as Quebec’s Bill 10, which has affected its Per Diem segment. Despite these challenges, Premier Health is focusing on cost reduction, debt management, and exploring growth opportunities in the Travel Nurses and Home Care sectors.

Executive/Board ChangesShareholder Meetings
Premier Health of America Inc. Reports Shareholder Meeting Results
Positive
May 1, 2025

Premier Health of America Inc. announced that all matters proposed at its annual general meeting on April 30, 2025, were approved by shareholders. Key decisions included the re-appointment of Raymond Chabot Grant Thornton LLP as auditor, the election of board members Pierre-Luc Toupin, Hubert Marleau, and Jean-Robert Pronovost, and the continuation of the incentive Stock Option Plan. The meeting saw participation from shareholders holding 54.49% of the total issued and outstanding shares, indicating strong stakeholder engagement and support for the company’s strategic direction.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.